Onset and outcome; A meta-analysis of escitalopram trials in depression

被引：0
作者：
Kasper, S. [1 ]
Andersen, H. [1 ]
Wade, A. [1 ]
机构：
[1] Univ Vienna, Vienna, Austria
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S259 / S259
页数：1
相关论文
共 5 条
[1]  
[Anonymous], C AM PSYCH ASS MAY 1
[2]   Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients [J].
Burke, WJ ;
Gergel, I ;
Bose, A .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (04) :331-336
[3]   Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care [J].
Lepola, UM ;
Loft, H ;
Reines, EH .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (04) :211-217
[4]  
Rapaport MH, 2004, J CLIN PSYCHIAT, V65, P44
[5]   Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care [J].
Wade, A ;
Lemming, OM ;
Hedegaard, KB .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 (03) :95-102
1